Colorado University researchers find promising drug [phenylbutyrate] for Parkinson's disease

---

Drug phenylbutyrate [ sold as "Buphenyl" ] already on market and sold by a division of Medicis Pharmaceutical Corp. (Scottsdale, AZ)


Denver Post -- 05 July 2011

By Margaret Jackson

"Colorado researchers have discovered a drug that stops the progression of Parkinson's disease in mice and is now being tested on humans.  Dr. Curt Freed and Wenbo Zhou have found that the drug phenylbutyrate turns on a gene ..."

http://www.denverpost.com/business/ci_18407428


Contact:  Margaret Jackson
tel: 303-954-1473
email:  mjackson@denverpost.com

-----

Other References:

http://en.wikipedia.org/wiki/Sodium_phenylbutyrate

--

http://en.wikipedia.org/wiki/Ucyclyd_Pharma

--

http://www.medicis.com  [ owns Ucyclyd Pharma ]

--

http://ureacycle.com  [ web site for Buphenyl ]


------

Dateline -- San Diego, Calif.:  08 July 2011 -- 11:00 PM

Researched & Posted by:

David A. Palella
Founder
BIOSCIENCE VENTURES Inc.

San Diego, California
cell: 619-787-5767
email:  dpalella@gmail.com
http://www.linkedin.com/in/davidpalella

web site:  http://www.BSVpartners.com

blog: http://biobizdev.blogspot.com


& Group Founder:

Infectious Disease R&D and Business Network
http://www.linkedin.com/e/-ubgx8c-godydbie-43/vgh/3937807/

Japan Biotech / Biopharma Partnering Forum
http://www.linkedin.com/e/vgh/2857975/

Biotech / Pharma Business Development, Licensing & Dealmaking
http://www.linkedin.com/e/-ubgx8c-gp40f4dt-22/vgh/3964633/


& Co-founder:

Stem Cells & Regenerative Medicine
http://www.linkedin.com/e/vgh/3921448

-----------